MedTrace Logo

Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant

NCT02297672 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-02-02

No results posted yet for this study

Summary

Permanent Breast Seed Implant (PBSI) has been demonstrated to be a well accepted and well tolerated form of partial breast radiotherapy. This protocol aims to build on the initial experience and to further refine the technique and collect toxicity and cost data, especially in comparison to alternate forms of breast radiotherapy.

Conditions

  • Early Stage Breast Cancer

Interventions

RADIATION

Stranded palladium seed interstitial implant

Interstitial implantation of stranded palladium 103 seeds in seroma with a margin

DEVICE

3 dimensional breast ultrasound

guidance of placement of interstitial needles in breast

DEVICE

Computerized tomography (CT)

Breast CT for planning and assessing interstitial implantation of radioactive seeds

Sponsors & Collaborators

  • British Columbia Cancer Agency

    lead OTHER

Principal Investigators

  • Juanita Crook, MD · British Columbia Cancer Agency

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2021-02-28
Completion
2026-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02297672 on ClinicalTrials.gov